Pete Hutson

Pete Hutson is an accomplished executive in the pharmaceutical and consulting industries, currently serving as Executive Director at ACADIA Pharmaceuticals Inc. since October 2018 and as Independent Business Owner of PeteHutson CNS Consulting LLC since August 2018. With a robust background in neuropsychiatric diseases, Pete Hutson provides expert consulting on conditions such as major depression, anxiety, and ADHD. Additionally, Pete Hutson has been an Adjunct Professor of Pharmacology and Physiology at Drexel University, College of Medicine, since January 2012. Previous roles include Senior Director in Neurobiology at Teva Pharma and Senior Director of Pharmacology at Shire Pharmaceuticals, alongside significant research positions at Merck. Pete Hutson holds a PhD in Pharmacology from University College, University of London.